Outcomes Similar for Temsirolimus/Bevacizumab and IFN/Bevacizumab for First-Line mRCC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Randomized Phase III Trial of Temsirolimus and Bevacizumab Versus Interferon Alfa and Bevacizumab in Metastatic Renal Cell Carcinoma: INTORACT Trial
J. Clin. Oncol 2013 Dec 02;[EPub Ahead of Print], BI Rini, J Bellmunt, J Clancy, K Wang, AG Niethammer, S Hariharan, B EscudierFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Renal Cell Carcinoma Center of Excellence
Visit our Renal Cell Carcinoma Center of Excellence for additional, in-depth coverage.